BGI Shenzhen

BGI (Chinese: 华大基因; pinyin: Huádà Jīyīn), known as the Beijing Genomics Institute prior to 2008, is one of the world’s premier genome sequencing centers. Its sequencing output is expected to soon surpass the equivalent of more than 15,000 human genomes per year. BGI will receive US$1.5 billion in “collaborative funds” over the next 10 years from the China Development Bank. BGI is producing de novo, resequenced genomes, RNA-Seq, Epigenomics, Metagenomics and Proteomics at such a high volume that genomes and research of significant impact are not listed here. For a complete reference of BGI's contribution to science, read a list of genomes sequenced at the bottom of this article.

Some content from Wikipedia, licensed under CC BY-SA

New evidence for genetic bases of liver cancer reported

The Asian Cancer Research Group (ACRG), an independent, not-for-profit company in collaboration with BGI, the world's largest genomics organization, and The University of Hong Kong (HKU), jointly announced the publication ...

Jul 01, 2013
popularity not rated yet | comments 0